Ontology highlight
ABSTRACT: Objectives
More than two years into the COVID-19 pandemic, SARS-CoV-2 still remains a global public health problem. Successive waves of infection have produced new SARS-CoV-2 variants with new mutations for which the impact on COVID-19 severity and patient survival is uncertain.Methods
A total of 764 SARS-CoV-2 genomes, sequenced from COVID-19 patients, hospitalized from 19th February 2020 to 30 April 2021, along with their clinical data, were used for survival analysis.Results
A significant association of B.1.1.7, the alpha lineage, with patient mortality (log hazard ratio (LHR) = 0.51, C.I. = [0.14,0.88]) was found upon adjustment by all the covariates known to affect COVID-19 prognosis. Moreover, survival analysis of mutations in the SARS-CoV-2 genome revealed 27 of them were significantly associated with higher mortality of patients. Most of these mutations were located in the genes coding for the S, ORF8, and N proteins.Conclusions
This study illustrates how a combination of genomic and clinical data can provide solid evidence for the impact of viral lineage on patient survival.
SUBMITTER: Loucera C
PROVIDER: S-EPMC9500738 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
Loucera Carlos C Perez-Florido Javier J Casimiro-Soriguer Carlos S CS Ortuño Francisco M FM Carmona Rosario R Bostelmann Gerrit G Martínez-González L Javier LJ Muñoyerro-Muñiz Dolores D Villegas Román R Rodriguez-Baño Jesus J Romero-Gomez Manuel M Lorusso Nicola N Garcia-León Javier J Navarro-Marí Jose M JM Camacho-Martinez Pedro P Merino-Diaz Laura L Salazar Adolfo de A Viñuela Laura L The Andalusian Covid-Sequencing Initiative Lepe Jose A JA Garcia Federico F Dopazo Joaquin J
Viruses 20220827 9
<h4>Objectives</h4>More than two years into the COVID-19 pandemic, SARS-CoV-2 still remains a global public health problem. Successive waves of infection have produced new SARS-CoV-2 variants with new mutations for which the impact on COVID-19 severity and patient survival is uncertain.<h4>Methods</h4>A total of 764 SARS-CoV-2 genomes, sequenced from COVID-19 patients, hospitalized from 19th February 2020 to 30 April 2021, along with their clinical data, were used for survival analysis.<h4>Resul ...[more]